Christophe Le Tourneau

Medical Oncologist, Head of the Phase I Program, Institut Curie, Paris · Department of Medical Oncology

  • Institut Curie, 26 rue d'Ulm, 75248 Paris Cedex 05


10 years, 8 months ago

Why are clinical studies important cancer researches?

Christophe Le Tourneau
Directory:
Cancer
Tags:
cancer research
cancer treatment
clinical research
clinical studies
EUTROC
molecular anomaly
oncogenes
Play
Current Time 0:00
/
Duration Time 0:00
Remaining Time -0:00
Loaded: 0%
Progress: 0%
00:00
Fullscreen
00:00
Mute
view in full page
10 years, 8 months ago

What are high throughput technologies to guide cancer therapy?

Christophe Le Tourneau
Directory:
Cancer
Tags:
EUTROC
high throughput technology
metastatic cancer
molecular targets
mutation
ovarian cancer
refractory cancer
SHIVA trial
translational research
tumor profiling
Play
Current Time 0:00
/
Duration Time 0:00
Remaining Time -0:00
Loaded: 0%
Progress: 0%
00:00
Fullscreen
00:00
Mute
view in full page
10 years, 8 months ago

What are Phase I, Phase II and Phase III clinical studies?

Christophe Le Tourneau
Directory:
Cancer
Tags:
clinical trial
EUTROC
informed consent
ovarian cancer
Phase III trial
Phase II trial
Phase I trial
safety
sponsor
translational research
Play
Current Time 0:00
/
Duration Time 0:00
Remaining Time -0:00
Loaded: 0%
Progress: 0%
00:00
Fullscreen
00:00
Mute
view in full page
10 years, 8 months ago

Describe the size and nature of SHIVA clinical study?

Christophe Le Tourneau
Directory:
Cancer
Tags:
EUTROC
high throughput technology
metastatic cancer
molecular targets
mutation
ovarian cancer
refractory cancer
SHIVA trial
translational research
tumor profiling
Play
Current Time 0:00
/
Duration Time 0:00
Remaining Time -0:00
Loaded: 0%
Progress: 0%
00:00
Fullscreen
00:00
Mute
view in full page
10 years, 8 months ago

Who can participate in a clinical study?

Christophe Le Tourneau
Directory:
Cancer
Tags:
cancer
chemotherapy
clinical trial
EUTROC
informed consent
ovarian cancer
personalized medicine
safety
sponsor
translational research
Play
Current Time 0:00
/
Duration Time 0:00
Remaining Time -0:00
Loaded: 0%
Progress: 0%
00:00
Fullscreen
00:00
Mute
view in full page
10 years, 8 months ago

Why are high throughput technologies helpful in the treatment of ovarian cancer?

Christophe Le Tourneau
Directory:
Cancer
Tags:
EUTROC
high throughput technology
metastatic cancer
molecular targets
mutation
ovarian cancer
refractory cancer
SHIVA trial
translational research
tumor profiling
Play
Current Time 0:00
/
Duration Time 0:00
Remaining Time -0:00
Loaded: 0%
Progress: 0%
00:00
Fullscreen
00:00
Mute
view in full page